Spatiotemporal Targeting of a Dual-Ligand Nanoparticle to Cancer Metastasis

Area of Science:

• Biomedical Engineering
• Nanotechnology
• Oncology

Background:

• Tumor microenvironments are dynamic and heterogeneous, with changing cell-surface biomarkers.
• Targeting specific cell-surface molecules on tumors is crucial for nanoparticle delivery.
• Existing single-ligand strategies may fail due to spatiotemporal biomarker expression changes.

Purpose of the Study:

• To investigate a dual-ligand nanoparticle for targeting two receptors overexpressed in aggressive tumors.
• To address spatiotemporal alterations in receptor expression patterns within cancer sites.
• To evaluate the efficacy of dual-ligand nanoparticles in targeting metastatic disease.

Main Methods:

• Developed a dual-ligand nanoparticle system utilizing peptides targeting P-selectin and αvβ3 integrin.
• Employed two mouse models of triple-negative breast cancer metastasis (MDA-MB-231 and 4T1 cells).
• Utilized in vivo multimodal imaging and post mortem histological analyses for evaluation.

Main Results:

• The dual-ligand nanoparticle effectively targeted metastatic disease, including sites missed by single-ligand strategies.
• The nanoparticles captured distinct metastatic sites overexpressing either or both targeted receptors.
• 22% of injected dual-ligand nanoparticles were found in early-stage metastases within 2 hours.

Conclusions:

• Dual-ligand nanoparticles offer a superior strategy for targeting heterogeneous and dynamic tumors.
• This approach enhances the detection and potential treatment of metastatic breast cancer.
• The dual-ligand system demonstrates high efficiency and broad applicability in targeting complex metastatic landscapes.